Evaluating service needs for veno-venous extracorporeal membrane oxygenation in patients with severe acute respiratory distress syndrome in Saskatchewan.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
17 10 2023
Historique:
received: 01 04 2023
accepted: 14 10 2023
medline: 23 10 2023
pubmed: 18 10 2023
entrez: 17 10 2023
Statut: epublish

Résumé

To determine the number of patients with acute respiratory distress syndrome (ARDS) who would be eligible to receive veno-venous extracorporeal membrane oxygenation (VV-ECMO). We conducted a retrospective observational study of ARDS patients admitted to Regina General Hospital Intensive Care Unit (ICU). VV-ECMO eligibility was assessed using selection criteria from the Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Syndrome trial (EOLIA), the Extracorporeal Life Support Organization (ELSO), New South Wales (NSW), Critical Care Services Ontario (CCSO) and a Regina-restrictive criteria. Of 415 patients admitted between October 16, 2018, and January 21, 2021, 103 (25%) had mild, 175 (42%) had moderate, and 64 (15%) had severe ARDS. Of the cohort, 144 (35%) had bacterial pneumonia, 86 (21%) had viral pneumonia (including COVID-19), and 72 (17%) had aspiration pneumonia. Using the EOLIA, ELSO, NSW, CCSO and Regina-restrictive criteria, 7/415 (1.7%), 6/415 (1.5%), 19/415 (4.6%), 26/415 (6.3%) and 12/415 (2.9%) were eligible for VV-ECMO, respectively. Of all ECMO-eligible patients, only one (2.4%) actually received VV-ECMO, 20/42 (48%) received prone positioning and 21/42 (50%) received neuromuscular blockade. There is potential for service expansion of VV-ECMO in Regina; however, there is still a need to improve the delivery of evidence-based ARDS therapies.

Identifiants

pubmed: 37848526
doi: 10.1038/s41598-023-45013-6
pii: 10.1038/s41598-023-45013-6
pmc: PMC10582080
doi:

Types de publication

Observational Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

17627

Informations de copyright

© 2023. Springer Nature Limited.

Références

Ranieri, V. M. et al. Acute respiratory distress syndrome: The Berlin Definition. JAMA J. Am. Med. Assoc. 307(23), 2526–2533 (2012).
Huppert, L. A., Matthay, M. A. & Ware, L. B. Pathogenesis of acute respiratory distress syndrome. Semin. Respir. Crit. Care Med. 40(1), 31–39 (2019).
doi: 10.1055/s-0039-1683996 pubmed: 31060086 pmcid: 7060969
Bellani, G. et al. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA 315(8), 788–800 (2016).
doi: 10.1001/jama.2016.0291 pubmed: 26903337
Munshi, L. et al. Venovenous extracorporeal membrane oxygenation for acute respiratory distress syndrome: A systematic review and meta-analysis. Lancet Respir. Med. 7(2), 163–172 (2019).
doi: 10.1016/S2213-2600(18)30452-1 pubmed: 30642776
Combes, A. et al. ECMO for severe ARDS: Systematic review and individual patient data meta-analysis. Intensive Care Med. 46(11), 2048–2057 (2020).
doi: 10.1007/s00134-020-06248-3 pubmed: 33021684 pmcid: 7537368
Peek, G. J. et al. CESAR: Conventional ventilatory support vs extracorporeal membrane oxygenation for severe adult respiratory failure. BMC Health Serv. Res. 23(6), 163 (2006).
doi: 10.1186/1472-6963-6-163
Combes, A. et al. Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. N. Engl. J. Med. 378(21), 1965–1975 (2018).
doi: 10.1056/NEJMoa1800385 pubmed: 29791822
Cho, H. W., Song, I. A. & Oh, T. K. Trends in extracorporeal membrane oxygenation treatment from 2005 to 2018 in South Korea. Perfusion 20, 02676591211018130 (2021).
Barbaro, R. P. et al. Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry. Lancet 396(10257), 1071–1078 (2020).
doi: 10.1016/S0140-6736(20)32008-0 pubmed: 32987008 pmcid: 7518880
Lee, B., Clay, A. & Sy, E. Evaluation of extracorporeal cardiopulmonary resuscitation eligibility criteria for out-of-hospital cardiac arrest patients. BMC Res. Notes 14(1), 139 (2021).
doi: 10.1186/s13104-021-05564-1 pubmed: 33858479 pmcid: 8051044
Sy, E. et al. Long-term safety of directly discharging patients home from the ICU compared to ward transfer. J. Intensive Care Med. 29, 08850666221090459 (2022).
Poses, R. M., McClish, D. K., Smith, W. R., Bekes, C. & Scott, W. E. Prediction of survival of critically ill patients by admission comorbidity. J. Clin. Epidemiol. 49(7), 743–747 (1996).
doi: 10.1016/0895-4356(96)00021-2 pubmed: 8691223
Ferreira, F. L., Bota, D. P., Bross, A., Mélot, C. & Vincent, J. L. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA 286(14), 1754–1758 (2001).
doi: 10.1001/jama.286.14.1754 pubmed: 11594901
Shekar, K. et al. Extracorporeal life support organization coronavirus disease 2019 interim guidelines: A consensus document from an international group of interdisciplinary extracorporeal membrane oxygenation providers. ASAIO J. 66(7), 707–721 (2020).
doi: 10.1097/MAT.0000000000001193 pubmed: 32604322
Forrest, P. et al. Retrieval of critically ill adults using extracorporeal membrane oxygenation: an Australian experience. Intensive Care Med. 37(5), 824–830 (2011).
doi: 10.1007/s00134-011-2158-8 pubmed: 21359610
Critical Care Services Ontario. ECMO Consultation Guidelines: Guidance Document for Ontario Hospitals [Internet] (2020). https://criticalcareontario.ca/wp-content/uploads/2020/10/ECMO-Consultation-Guidelines_Guidance-Document-for-Ontario-Hospitals-FINAL-2020.pdf [cited 2021 Aug 13].
Tonna, J. E. et al. Management of adult patients supported with Venovenous Extracorporeal Membrane Oxygenation (VV ECMO): Guideline from the Extracorporeal Life Support Organization (ELSO). ASAIO J. Am. Soc. Artif. Intern. Organs 67(6), 601–610 (2021).
doi: 10.1097/MAT.0000000000001432
Statistics Canada. Population Projections for Canada (2021 to 2068), Provinces and Territories (2021 to 2043) [Internet] (2022). https://www150.statcan.gc.ca/n1/pub/91-520-x/91-520-x2022001-eng.htm [cited 2023 Oct 3].
Barbaro, R. P. et al. Association of hospital-level volume of extracorporeal membrane oxygenation cases and mortality. Analysis of the extracorporeal life support organization registry. Am. J. Respir. Crit. Care Med. 191(8), 894–901 (2015).
doi: 10.1164/rccm.201409-1634OC pubmed: 25695688 pmcid: 4435456
Rabie, A. A. et al. Implementation of new ECMO centers during the COVID-19 pandemic: Experience and results from the Middle East and India. Intensive Care Med. 47(8), 887–895 (2021).
doi: 10.1007/s00134-021-06451-w pubmed: 34156477 pmcid: 8217786
Nagaoka, E. et al. Efficacy of multidisciplinary team approach with extracorporeal membrane oxygenation for COVID-19 in a low volume ECMO center. Artif. Organs 45(9), 1061–1067 (2021).
doi: 10.1111/aor.13947 pubmed: 33656783 pmcid: 8014198
Combes, A. et al. Position paper for the organization of extracorporeal membrane oxygenation programs for acute respiratory failure in adult patients. Am. J. Respir. Crit. Care Med. 190(5), 488–496 (2014).
doi: 10.1164/rccm.201404-0630CP pubmed: 25062496
Karagiannidis, C. et al. Extracorporeal membrane oxygenation: evolving epidemiology and mortality. Intensive Care Med. 42(5), 889–896 (2016).
doi: 10.1007/s00134-016-4273-z pubmed: 26942446
Duggal, A. et al. Implementation of protocolized care in ARDS improves outcomes. Respir. Care 66(4), 600–609 (2021).
doi: 10.4187/respcare.07999 pubmed: 33051253
Goligher, E. C. et al. Clinical strategies for implementing lung and diaphragm-protective ventilation: Avoiding insufficient and excessive effort. Intensive Care Med. 46(12), 2314–2326 (2020).
doi: 10.1007/s00134-020-06288-9 pubmed: 33140181 pmcid: 7605467

Auteurs

Barsa Saha (B)

School of Public Health, University of Saskatchewan, 107 Wiggins Rd, Saskatoon, SK, S7N 5E5, Canada.

Savannah Drapak (S)

School of Health Sciences, Saskatchewan Polytech, 4635 Wascana Pkwy, Regina, SK, S4P 3A3, Canada.

Jonathan F Mailman (JF)

Pharmacy Department, Royal Jubilee Hospital, Vancouver Island Health Authority, Victoria, BC, V8R 1J8, Canada.
College of Medicine, University of Saskatchewan, 1440-14th Avenue, Regina, SK, S4P 0W5, Canada.
Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, V6T 1Z3, Canada.

Sandy Kassir (S)

Research Department, Saskatchewan Health Authority, Wascana Rehabilitation Centre, 2180-23 Ave, Regina, SK, S4S 0A5, Canada.

Eric Sy (E)

College of Medicine, University of Saskatchewan, 1440-14th Avenue, Regina, SK, S4P 0W5, Canada. ers728@usask.ca.
Department of Critical Care, Saskatchewan Health Authority, 1440-14th Avenue, Regina, SK, S4P 0W5, Canada. ers728@usask.ca.
Surgical Intensive Care Unit, Regina General Hospital, 1440-14 Avenue, Regina, SK, S4P 0W5, Canada. ers728@usask.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH